Recommendation by the Nomination Committee concerning Board

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jan 30, 2014 at 4:45 AM

Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2014 AGM of Orion Corporation

ORION CORPORATION STOCK EXCHANGE RELEASE 30 JANUARY 2014 at 11.40 a.m. EET Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2014 AGM of Orion Corporation The Nomination Committee of Orion Corporation has given on 30 January 2014 its recommendation to the Board of Directors of the company for the proposal to the Annual General Meeting of 2014 concerning the composition of the Board of Directors to be elected. The Committee recommends that the following proposal be presented to the AGM of 2014: The number of Board members would be seven. The present Board members, Sirpa Jalkanen, Eero Karvonen, Timo Maasilta, Hannu Syrjänen, Heikki Westerlund and Jukka Ylppö would be re-elected and Mikael Silvennoinen, M. Sc. (Economics) would be elected as a new member for the next term of office. Hannu Syrjänen would be re-elected as Chairman. Mikael Silvennoinen, M. Sc. (Economics), born 1956, is the executive chairman of IMS Talent Oy. Silvennoinen has over 20 years experience of management positions in Pohjola Bank Plc, lastly (1997-2013) as the President and CEO and Chairman of the Executive Committee of the bank. Previously he has worked in various treasury positions in Wärtsilä Corporation, lastly as a Group treasurer. Silvennoinen is the Chairman of the Board of IMS Talent Oy and a board member in Konecranes Plc and The Finnish Foundation for Share Promotion (Suomen Pörssisäätiö). His earlier positions of trust include among others position of Chairman of the Board of Directors in Pohjola Insurance Ltd, Pohjola Asset Management Ltd and Helsinki OP Retail Bank Plc as well as board memberships in Pohjola Group Oyj and Unico Banking Group. The Nomination Committee also announces as its recommendation that the following remunerations be paid to the Board of Directors: As an annual fee, the Chairman would receive EUR 76,000, the Vice Chairman would receive EUR 51,000 and the other members would receive EUR 38,000 each. As a fee for each meeting attended, the Chairman would receive EUR 1,200, the Vice Chairman would receive EUR 900 and the other members would receive EUR 600 each. The travel expenses of the Board members would be paid in accordance with previously adopted practice. The aforementioned fees would also be paid to the Chairmen and to the members of the committees established by the Board, for each committee meeting attended. Of the annual fee, 60% would be paid in cash and 40% in Orion Corporation B- shares, which would be acquired to the members during 31 March-4 April 2014 from the stock exchange in amounts corresponding to EUR 30,400 for the Chairman, EUR 20,400 for the Vice Chairman and EUR 15,200 for each of the other members. The part of the annual fee that is to be paid in cash corresponds to the approximate sum necessary for the payment of the income taxes on the fees and would be paid no later than 30 April 2014. The annual fees shall encompass the full term of office of the Board of Directors. The Nomination Committee has not given its recommendation for the remunerations to the Board of Directors, but the matter will be proposed by a shareholder at the AGM. The Nomination Committee has consisted of the following members: Matti Kavetvuo, Chairman, Kari Jussi Aho, Timo Ritakallio, Seppo Salonen, Hannu Syrjänen and Jukka Ylppö. Orion Corporation Timo Lappalainen Olli Huotari President and CEO SVP, Corporate Functions Contact person: Hannu Syrjänen, Chairman of the Board of Directors of Orion Corporation phone +358 400 454 885 A photograph of Mikael Silvennoinen is downloadable from: http://www.orion.fi/msilvennoinen Publisher: Orion Corporation Communications Orionintie 1A, FI-02200 Espoo, Finland Homepage: www.orion.fi Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs. Orion's net sales in 2012 amounted to EUR 980 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki. [HUG#1758005]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Western Microsurgical Expands Through Strategic Acquisitions

Western Microsurgical's Bold Moves Western Microsurgical (WMS) is out here making waves, pulling off some serious strategic plays with the acquisitions of Q Surgical and Proficient Surgical. Now, this ain't some fly-by-night decision—this is about securing territory and leveling up their game in surgical microscopes and operating room supplies. With a footprint that'll...

EDGE Sound Research Boosted by $2M from Stormbreaker

EDGE Sound Research: Shaping Future with Sound Folks are starting to whisper more about EDGE Sound Research these days, and for good reason. This little outfit based out of Riverside, California just took in another $2 million from Stormbreaker Ventures, lifting its total funding to $9 million. But what are they doing with all that cash? They're building the perception...

Latham & Harvey Boost Fund Formation With AI Tech

AI Joins Forces with Legal Expertise Latham & Watkins LLP and Harvey are teaming up to revolutionize how fund formation gets done. They're jumping into the AI waters with both feet, aiming to make the fund documentation process less of a nightmare and more of a breeze for lawyers. The idea isn't just to cut down on the grunt work, but to let attorneys zero in on what's...

Cracking the Last-Mile 'Fragmentation Tax' Challenge

Tackling Last-Mile Delivery Woes It's like trying to put a square peg in a round hole. That's what last-mile delivery feels like right now with the burden we're seeing in EMEA—costs shooting up by 9% just this past year. Anyone in logistics knows that red ink doesn't just dry up on its own. According to FarEye, 96% of companies are coughing up more dough per delivery,...

Shrieve Expands with Clear Solutions Takeover

Strategic Acquisition with Environmental Edge Who'd have thought Shrieve Chemical and Clear Solutions would hitch their wagons? This move, caught from the windy plains of Texas to the greens of Shrewsbury, has all the makings of a sharp strategic pairing. Shrieve Chemical, backed by Gemspring Capital, has swallowed UK-based Clear Solutions, a feisty name in water-based...

Lear Capital Hits $5 Billion Milestone: Trust or Hype?

A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...

Webull Faces Class Action: Deadline Looms Dec 2026

Sinking Shares: The Webull Saga Unfolds Shady business practices can really make a stock take a nosedive, and that's what's happening with Webull Corporation, trading under NASDAQ:BULL. The alarm bells started ringing when the truth about their operations and ties to China came out. Turns out, what looked like a stable American fintech platform had its roots digging deep...

Steel Vet Shift: John Pritchett Takes Helm at Trojan

Trojan Steel's Bold Move with John Pritchett at the Helm Trojan Steel is changing the game by appointing John C. Pritchett as its new President. This isn't just another shuffle of suits in the boardroom—it's a statement. Pritchett isn't some steel industry old-timer; instead, he's a business leader with a knack for scaling operations. With a resume that includes...

OriginPoint Boosts Growth with $200M Lender Team

Mortgage Powerhouses Join Forces with OriginPoint It's not every day you see a $200 million mortgage team making a beeline for new pastures, but today's landscape seems ripe for such moves. Enter the We Fund LA team, led by mortgage veterans Daniel Arias and Ron Sequeira, as they align with OriginPoint Mortgage to scale new heights in Southern California. This isn't just...

Coulomb Solutions Powers Ahead with ReadyGrid Launch

Breaking New Ground with ReadyGrid If you've been keeping an eye on the energy storage landscape, today's a big day. Coulomb Solutions, Inc. (CSI) is shaking things up by spinning off ReadyGrid, its own dedicated mobile energy storage powerhouse. The move is designed to tackle the pressing power challenges that have been nagging industries across the board, from...